1-2 of 2
Juan Luis Reguera-Ortega
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma

Inés Zugasti, Marta Tormo-Ratera, Aina Oliver-Caldes, Juan Carlos Soler-Perromat, Veronica Gonzalez-Calle, David F Moreno, Valentín Cabañas, Nieves Lopez-Muñoz, Alvaro Bartolome-Solanas, Marta Español-Rego, Juan Luis Reguera-Ortega, Laura Rosiñol, Lucia Lopez-Corral, Natalia Tovar, Luis Gerardo Rodríguez-Lobato, Rosa Maria Alvarez Perez, Sara Varea, Eulàlia Olesti, Adolfo Gomez Grande, Laura Frutos, Pilar Tamayo, Manel Juan, José M Moraleda, Álvaro Urbano-Ispizua, Europa Azucena Azucena González-Navarro, Joaquín Martínez-López, Maria-Victoria Mateos, Xavier Tomas, Xavier Setoain, Carlos Fernández de Larrea
Journal: Blood Advances
Blood Adv bloodadvances.2024014360.
https://doi.org/10.1182/bloodadvances.2024014360
Published: 2024
Includes: Supplemental data
Journal Articles

Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma

Gloria Iacoboni, Kai Rejeski, Guillermo Villacampa, Jaap A. van Doesum, Annalisa Chiappella, Francesca Bonifazi, Lucia Lopez-Corral, Michiel van Aalderen, Mi Kwon, Nuria Martínez-Cibrian, Stefania Bramanti, Juan Luis Reguera-Ortega, Lina Camacho-Arteaga, Christian Schmidt, Ana Marín-Niebla, Marie José Kersten, Alejandro Martin Garcia-Sancho, Pier Luigi Zinzani, Paolo Corradini, Tom van Meerten, Marion Subklewe, Pere Barba
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3606–3610.
https://doi.org/10.1182/bloodadvances.2021006922
Published: 2022
Includes: Supplemental data